Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Antigenicity of Rebif New Formulation in Relapsing MS
NCT00110396Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Jan 2005
- Primary completion
- Apr 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon beta in multiple sclerosis (MS), sponsored by EMD Serono. Started Jan 2005; status: completed.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00110396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110396.